
Drovix provides bilateral OTC liquidity to professional and institutional counterparties. Clients face Drovix as principal counterparty. Drovix is not an exchange, MTF, OTF, ECN or retail trading venue.
How Drovix acts as counterparty
Drovix does not operate a public exchange or multilateral trading facility. Liquidity is provided bilaterally between Drovix and approved institutional counterparties under written agreements, defined credit terms and applicable regulatory frameworks.
Approved counterparties face Drovix as principal in bilateral OTC transactions. Drovix is not a public exchange, MTF, OTF or ECN. Drovix does not match third-party orders on a multilateral venue.
Drovix manages resulting market risk through internal risk controls, external liquidity relationships, hedging arrangements and inventory management, within defined market-risk, credit-risk, liquidity-risk and concentration-risk limits.
Access is limited to professional clients, eligible counterparties, regulated financial institutions, funds, proprietary trading firms, brokers and other institutional clients. Drovix does not onboard retail clients.
Every fill is benchmarked. Post-trade TCA, venue-level attribution and best-execution reporting are delivered in machine-readable form, suitable for institutional best-execution committees and internal audit.
FIX 4.4, REST and WebSocket. No proprietary client required. EMS/OMS and prime-broker integrations supported. Optional MT5 bridge for approved counterparties only.
Risk transfer is governed by counterparty credit limits, margin frameworks, pre-trade checks, kill-switch controls and post-trade reconciliation. Limits and exposures are monitored in real time.
Important. Drovix provides services only to professional clients, eligible counterparties and institutional clients where permitted by applicable law. Drovix does not provide services to retail clients, does not accept retail deposits and does not offer retail trading accounts. Regulatory authorisations apply only to the specific legal entity to which they are granted and do not extend automatically to any affiliated entity, group company or brand.